Genter Capital Taxable Quality Intermediate ETF (GENT)

That sidesteps the point.

I am not defending every theory posted by every investor about the MHRA timeline. I am addressing your categorical argument: no tissue-agnostic biomarker, therefore no tissue-agnostic or platform pathway.

That argument still fails.

I think the winner here is a Deutche bank London transfer to California investors…
Big win maybe or a big wind down??? 
I’m sure the transaction even 10 cents on the dollar is 100 million plus… how long they want to sit on that investment??  Back in March. 
I seen on the filing

in the morning trade brigade does
market take so i do not need this guy

Not surprised to see this dip after no one buying those 03s ! Waiting for some juicy updates hopefully 🤞 

Keep your eyes peeled for the CC press release either tomorrow morning or Thursday morning.

June 15: 10-K
June 16: Mikah conference call

Thanks.

Good to go https://eservices.bcsc.bc.ca/eservices/docview/temp/BCSC_ReportingIssuers.pdf?t=1591900504955

You are not identifying a regulatory impossibility; you are identifying that DCVax does not fit a pathway FDA created for a different new class of drugs. That is not a rebuttal to the platform thesis. It is the class error.

----

So , no, this is not about verbiage. It i

I guess it is fair to say : Kiss it good bye. 4 years in the waiting for nothing what a shame…

alright well go on Twitter and make a judge Judy of yourself man there only OTC retards on here and that includes myself

Addendum - from AI
Hearing Date: The UPC hearing is set for September 29, 2026, with a decision anticipated from the court within weeks following the hearing.

Not an obituary. Still speculation. “I’m hearing…” is not factual information.

Excellent find, Yoda!  Great potential connection direct to the president. 

I am not sure how the silver mine deal proceeds or others.

Since Hiru never posted a bond the plaintiff could have gone after assets at any time. I was surprised there was no prior activity. It appears they were either waiting for the appeal to conclude or doing investigative work.

Scinai Immunotherapeutics Ltd.
Jerusalem BioPark, 2nd Floor
Hadassah Ein Kerem Campus
Jerusalem
Israel

www.scinai.com

Interesting action lately … need some updates from company !! 

Scinai Immunotherapeutics Ltd. is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases.

Good… I’ll keep buying.   

https://x.com/i/status/2063989669667180674

https://x.com/i/status/2063989669667180674

I try to post on the RKT board however if you dare to call out the liars and misinformation that’s been posted for 17 years you end up here.

Sure sounds like projection !

brooktrail1933 The U.K. is not a big fan of the U.S. Add to that there are more than 5 million Muslims living in the U.K. Could one guess that at least 25% are anti American? Of those 25%, how many does the MHRA employ?
NWBO is a US company. Doesn't take much of an imagination to see th

I agree 100% Chiugray. They can whistleblow on their peers and who they are working with and way many, many times what they are now, likely a fortune, IMHO. Have a wonderful day!

There is an upcoming public oral hearing scheduled in Enanta Pharmaceuticals' European patent infringement case against Pfizer over the COVID-19 antiviral drug Paxlovid.

The Unified Patent Court (UPC) of the European Union has scheduled the hearing for September 29, 2026.Case Details:

Satter claim that USA has no courts(?): not literacy.